Top Mid Cap Stocks To Add to Your Watchlist - December 16th
I'm LongbridgeAI, I can summarize articles.MarketBeat's stock screener tool highlights five Mid Cap stocks to watch: ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Akero Therapeutics, AltC Acquisition, and Applied Digital. These stocks have shown high trading volumes recently. Mid-cap stocks offer moderate growth potential with moderate risk and liquidity. ProShares UltraPro Short QQQ seeks to triple the inverse performance of the NASDAQ-100 Index. Akero Therapeutics is developing treatments for metabolic diseases. AltC Acquisition is a blank-check company. Applied Digital provides digital infrastructure solutions.
- Bear Market Funds to Watch This Year
ProShares UltraPro Short QQQ, Direxion Daily TSLA Bull 2X Shares, Akero Therapeutics, AltC Acquisition, and Applied Digital are the five Mid Cap stocks to watch today, according to MarketBeat's stock screener tool. Mid-cap stocks are shares of companies with medium-sized market capitalizations, typically in the roughly $2 billion to $10 billion range (definitions vary by index or provider). Investors view them as a middle ground between small-cap growth and large-cap stability, offering moderate growth potential with moderate risk and liquidity. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
- 7 best bear market ETFs to battle a decline
Read Our Latest Research Report on SQQQ
Direxion Daily TSLA Bull 2X Shares (TSLL)
Read Our Latest Research Report on TSLL
Akero Therapeutics (AKRO)
- Should You Bet Against The Nasdaq 100 With This Inverse ETF?
Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients.
Read Our Latest Research Report on AKRO
AltC Acquisition (ALCC)
AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.
Read Our Latest Research Report on ALCC
Applied Digital (APLD)
Applied Digital Corporation designs, develops, and operates datacenters in North America. Its datacenters provide digital infrastructure solutions to the high-performance computing industry. The company also provides artificial intelligence cloud services, high performance computing datacenter hosting, and crypto datacenter hosting services.
Read Our Latest Research Report on APLD
See Also
- MarketBeat's Top Five Stocks to Own in December 2025
- Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026
- AI Runs on Power—And Constellation Energy Controls the Switch
- 3 Insider Moves You Shouldn’t Ignore Heading Into 2026
- 3 AI Names With Big Buybacks: GEV, PSTG, and LSCC Signal Confidence
- Western Digital’s Nasdaq-100 Entry Caps Its AI-Driven Comeback
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in ProShares UltraPro Short QQQ Right Now?
Before you consider ProShares UltraPro Short QQQ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ProShares UltraPro Short QQQ wasn't on the list.
While ProShares UltraPro Short QQQ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
